Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder

Julie A. Marusich, William Travis McCuddy, Joshua S. Beckmann, Cassandra Gipson-Reichardt, Michael T. Bardo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Despite its abuse potential, methylphenidate (MPH) is widely prescribed for treatment of attention-deficit hyperactivity disorder (ADHD). The purpose of the present study was to examine MPH self-administration in a rat model of ADHD. Experiment 1 examined the acquisition of MPH self-administration and assessed the MPH dose-effect curve in spontaneously hypertensive rats (SHR), an inbred rat model of ADHD, Wistar Kyotos (WKY), the progenitor strain for SHR, and Sprague-Dawley (SD), an outbred control strain. Experiment 2 replicated Experiment 1, but replaced MPH infusions with sucrose pellets. Initial acquisition of MPH self-administration was greater in SHR and SD than WKY. However, with extended training using an incrementing fixed ratio schedule SHR and WKY did not differ in responding for MPH using the training dose (0.3 mg/kg/infusion) or other unit doses, except that SHR showed greater responding than WKY at 0.1 mg/kg/infusion. SHR also showed greater acquisition and maintenance of sucrose-reinforced responding compared with both WKY and SD. Greater initial acquisition of MPH self-administration in SHR than WKY may not be due to a strain-specific difference in sensitivity to the reinforcing effect of MPH.

Original languageEnglish (US)
Pages (from-to)794-804
Number of pages11
JournalBehavioural Pharmacology
Volume22
Issue number8
DOIs
StatePublished - Dec 2011
Externally publishedYes

Fingerprint

Methylphenidate
Self Administration
Attention Deficit Disorder with Hyperactivity
Sucrose
Inbred SHR Rats
Appointments and Schedules
Maintenance

Keywords

  • methylphenidate
  • rat
  • self-administration
  • spontaneously hypertensive rats
  • Wistar Kyotos

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder. / Marusich, Julie A.; McCuddy, William Travis; Beckmann, Joshua S.; Gipson-Reichardt, Cassandra; Bardo, Michael T.

In: Behavioural Pharmacology, Vol. 22, No. 8, 12.2011, p. 794-804.

Research output: Contribution to journalArticle

Marusich, Julie A. ; McCuddy, William Travis ; Beckmann, Joshua S. ; Gipson-Reichardt, Cassandra ; Bardo, Michael T. / Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder. In: Behavioural Pharmacology. 2011 ; Vol. 22, No. 8. pp. 794-804.
@article{60bee9f3b6594d04b6793d53de5cf7c5,
title = "Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder",
abstract = "Despite its abuse potential, methylphenidate (MPH) is widely prescribed for treatment of attention-deficit hyperactivity disorder (ADHD). The purpose of the present study was to examine MPH self-administration in a rat model of ADHD. Experiment 1 examined the acquisition of MPH self-administration and assessed the MPH dose-effect curve in spontaneously hypertensive rats (SHR), an inbred rat model of ADHD, Wistar Kyotos (WKY), the progenitor strain for SHR, and Sprague-Dawley (SD), an outbred control strain. Experiment 2 replicated Experiment 1, but replaced MPH infusions with sucrose pellets. Initial acquisition of MPH self-administration was greater in SHR and SD than WKY. However, with extended training using an incrementing fixed ratio schedule SHR and WKY did not differ in responding for MPH using the training dose (0.3 mg/kg/infusion) or other unit doses, except that SHR showed greater responding than WKY at 0.1 mg/kg/infusion. SHR also showed greater acquisition and maintenance of sucrose-reinforced responding compared with both WKY and SD. Greater initial acquisition of MPH self-administration in SHR than WKY may not be due to a strain-specific difference in sensitivity to the reinforcing effect of MPH.",
keywords = "methylphenidate, rat, self-administration, spontaneously hypertensive rats, Wistar Kyotos",
author = "Marusich, {Julie A.} and McCuddy, {William Travis} and Beckmann, {Joshua S.} and Cassandra Gipson-Reichardt and Bardo, {Michael T.}",
year = "2011",
month = "12",
doi = "10.1097/FBP.0b013e32834d623e",
language = "English (US)",
volume = "22",
pages = "794--804",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder

AU - Marusich, Julie A.

AU - McCuddy, William Travis

AU - Beckmann, Joshua S.

AU - Gipson-Reichardt, Cassandra

AU - Bardo, Michael T.

PY - 2011/12

Y1 - 2011/12

N2 - Despite its abuse potential, methylphenidate (MPH) is widely prescribed for treatment of attention-deficit hyperactivity disorder (ADHD). The purpose of the present study was to examine MPH self-administration in a rat model of ADHD. Experiment 1 examined the acquisition of MPH self-administration and assessed the MPH dose-effect curve in spontaneously hypertensive rats (SHR), an inbred rat model of ADHD, Wistar Kyotos (WKY), the progenitor strain for SHR, and Sprague-Dawley (SD), an outbred control strain. Experiment 2 replicated Experiment 1, but replaced MPH infusions with sucrose pellets. Initial acquisition of MPH self-administration was greater in SHR and SD than WKY. However, with extended training using an incrementing fixed ratio schedule SHR and WKY did not differ in responding for MPH using the training dose (0.3 mg/kg/infusion) or other unit doses, except that SHR showed greater responding than WKY at 0.1 mg/kg/infusion. SHR also showed greater acquisition and maintenance of sucrose-reinforced responding compared with both WKY and SD. Greater initial acquisition of MPH self-administration in SHR than WKY may not be due to a strain-specific difference in sensitivity to the reinforcing effect of MPH.

AB - Despite its abuse potential, methylphenidate (MPH) is widely prescribed for treatment of attention-deficit hyperactivity disorder (ADHD). The purpose of the present study was to examine MPH self-administration in a rat model of ADHD. Experiment 1 examined the acquisition of MPH self-administration and assessed the MPH dose-effect curve in spontaneously hypertensive rats (SHR), an inbred rat model of ADHD, Wistar Kyotos (WKY), the progenitor strain for SHR, and Sprague-Dawley (SD), an outbred control strain. Experiment 2 replicated Experiment 1, but replaced MPH infusions with sucrose pellets. Initial acquisition of MPH self-administration was greater in SHR and SD than WKY. However, with extended training using an incrementing fixed ratio schedule SHR and WKY did not differ in responding for MPH using the training dose (0.3 mg/kg/infusion) or other unit doses, except that SHR showed greater responding than WKY at 0.1 mg/kg/infusion. SHR also showed greater acquisition and maintenance of sucrose-reinforced responding compared with both WKY and SD. Greater initial acquisition of MPH self-administration in SHR than WKY may not be due to a strain-specific difference in sensitivity to the reinforcing effect of MPH.

KW - methylphenidate

KW - rat

KW - self-administration

KW - spontaneously hypertensive rats

KW - Wistar Kyotos

UR - http://www.scopus.com/inward/record.url?scp=80855132915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855132915&partnerID=8YFLogxK

U2 - 10.1097/FBP.0b013e32834d623e

DO - 10.1097/FBP.0b013e32834d623e

M3 - Article

VL - 22

SP - 794

EP - 804

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 8

ER -